{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Familial tumour syndromes of the central and peripheral nervous system",
      "relation": "contraindication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_doxorubicin",
          "name": "Doxorubicin"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_cyclophosphamide",
          "name": "Cyclophosphamide"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_busulfan",
          "name": "Busulfan"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_vincristine",
          "name": "Vincristine"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_fluorouracil",
          "name": "Fluorouracil"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_temozolomide",
          "name": "Temozolomide"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_thalidomide",
          "name": "Thalidomide"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_chlorambucil",
          "name": "Chlorambucil"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_ifosfamide",
          "name": "Ifosfamide"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_lomustine",
          "name": "Lomustine"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_nitrosourea",
          "name": "Nitrosourea"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "n_doxorubicin",
          "type": "Drug",
          "label": "Doxorubicin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_cyclophosphamide",
          "type": "Drug",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_busulfan",
          "type": "Drug",
          "label": "Busulfan",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_vincristine",
          "type": "Drug",
          "label": "Vincristine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_fluorouracil",
          "type": "Drug",
          "label": "Fluorouracil",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_temozolomide",
          "type": "Drug",
          "label": "Temozolomide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_thalidomide",
          "type": "Drug",
          "label": "Thalidomide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_chlorambucil",
          "type": "Drug",
          "label": "Chlorambucil",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ifosfamide",
          "type": "Drug",
          "label": "Ifosfamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_lomustine",
          "type": "Drug",
          "label": "Lomustine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_nitrosourea",
          "type": "Drug",
          "label": "Nitrosourea",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_familial_tumor_syndromes",
          "type": "Disease",
          "label": "Familial tumour syndromes of the central and peripheral nervous system",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "n_doxorubicin",
          "target": "n_familial_tumor_syndromes",
          "relation": "contraindication",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "根据常见的药物不良反应，Doxorubicin 可能对神经系统肿瘤有负面影响"
        },
        {
          "source": "n_cyclophosphamide",
          "target": "n_familial_tumor_syndromes",
          "relation": "contraindication",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Cyclophosphamide 与神经系统肿瘤的关联性较强"
        },
        {
          "source": "n_busulfan",
          "target": "n_familial_tumor_syndromes",
          "relation": "contraindication",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已知 Busulfan 对神经系统有可能的负面作用"
        },
        {
          "source": "n_vincristine",
          "target": "n_familial_tumor_syndromes",
          "relation": "contraindication",
          "weight": 0.78,
          "agent": "Proponent",
          "rationale": "Vincristine 的神经毒性在患者中已有报告"
        },
        {
          "source": "n_methotrexate",
          "target": "n_familial_tumor_syndromes",
          "relation": "contraindication",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Methotrexate 可能导致神经系统副作用"
        },
        {
          "source": "n_fluorouracil",
          "target": "n_familial_tumor_syndromes",
          "relation": "contraindication",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Fluorouracil 对神经系统存在潜在风险"
        },
        {
          "source": "n_temozolomide",
          "target": "n_familial_tumor_syndromes",
          "relation": "contraindication",
          "weight": 0.68,
          "agent": "Proponent",
          "rationale": "临床观察显示 Temozolomide可能造成神经损害"
        },
        {
          "source": "n_thalidomide",
          "target": "n_familial_tumor_syndromes",
          "relation": "contraindication",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "Thalidomide 可能影响神经系统，需谨慎使用"
        },
        {
          "source": "n_chlorambucil",
          "target": "n_familial_tumor_syndromes",
          "relation": "contraindication",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "有报告提示 Chlorambucil 可能对神经系统有影响"
        },
        {
          "source": "n_ifosfamide",
          "target": "n_familial_tumor_syndromes",
          "relation": "contraindication",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "Ifosfamide 的作用需考虑神经系统风险"
        },
        {
          "source": "n_lomustine",
          "target": "n_familial_tumor_syndromes",
          "relation": "contraindication",
          "weight": 0.53,
          "agent": "Proponent",
          "rationale": "Lomustine 可能与神经系统肿瘤发生有关"
        },
        {
          "source": "n_nitrosourea",
          "target": "n_familial_tumor_syndromes",
          "relation": "contraindication",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "Nitrosourea 在临床中显示的神经损害风险"
        }
      ],
      "merge": [],
      "set_weights": []
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "多种药物存在与中枢及周围神经系统家族性肿瘤综合征的潜在禁忌",
        "confidence": "high"
      }
    ],
    "assumptions": [
      "各药物对神经系统的影响根据现有临床观察与研究辅助判断"
    ],
    "uncertainties": [
      "药物的个体差异可能导致不良反应存在变异性"
    ],
    "next_focus_for_pi": [
      "进一步研究不同药物在家族性肿瘤综合征患者中的安全性"
    ]
  }
}